跳至主要内容
临床试验/IRCT20231004059608N1
IRCT20231004059608N1招募中3 期

Assessment the Efficacy of Lactoferin as a Natural Product in Virus Clearance in HPV+ Patients: Randomized Double Blind Clinical trial

Pasture Institute of Iran0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 50 years(—)
性别
Female

入选标准

  • Age: 25 to 50 years
  • Gender: Female
  • Marital Status: Married/Single
  • HPV positive patients (genotypes 16, 18, 31, 33, 39, 45, and 52)
  • Normal pap smear
  • Low grade pathology / CIN1

排除标准

  • Pregnant women
  • observation of internal/external warts
  • history of surgery
  • ?alchohol consumption
  • AIDS (HIV+)
  • Drug use within 90 days
  • People with systemic immunosuppressive disorders
  • Patients who have received local or systemic treatment in the last three months.
  • Abnormal pap smear
  • High grade pathology
  • Conization history
  • Suffering from chronic diseases (diabetes, fatty liver and metabolic diseases, etc.)
  • Having more than 3 sexual partners
  • Patients with a history of treatment with Eldara and similar drugs (local and systemic)
  • History of Allergy, sensitivity to medicine, Anaphylaxis shock

研究者

发起方
Pasture Institute of Iran

相似试验

Efficacy of Lactoferin in HPV Clearance | 临床试验